$IRMD SEC Filings

Filed On	Filing
27 Oct 2026	SCHEDULE 13G/A
25 Sep 2026	Form 4: Kiani Joe E, Director Received 698 shares by exercise or conversion
08 Sep 2026	Form 4: Allen Monty K, Director Sold 1,419 shares ($123K)
03 Sep 2026	144
18 Aug 2026	8-K/A: Results of Operations and Financial Condition Orlando, Florida, July 31, 2026 – IRADIMED CORPORATION (the “Company” or “Iradimed”) (NASDAQ: IRMD) announced today its financial results for the three and six months ended June 30, 2026. The Company is a leader in developing innovative ...
31 Jul 2026	10-Q
31 Jul 2026	8-K: Other Events
28 Jul 2026	SCHEDULE 13G
24 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
23 Jun 2026	Form 4: Glenn John, CFO Received 5,796 shares by exercise or conversion · Gave up 2,319 shares to cover exercise price or tax ($214K)
04 Jun 2026	Form 4: Scharen-Guivel Hilda Frederique, Director Sold 3,000 shares ($285K)
04 Jun 2026	144
02 Jun 2026	Form 4: Susi Roger E., Director Sold 2,500 shares ($227K)
28 May 2026	Form 4: Susi Roger E., Director Sold 5,000 shares ($461K) · Sold 2,500 shares ($230K)
20 May 2026	Form 4: Susi Roger E., Director Sold 5,000 shares ($438K) · Sold 2,500 shares ($220K)
14 May 2026	SCHEDULE 13G/A
13 May 2026	Form 4: Susi Roger E., Director Sold 3,089 shares ($261K) · Sold 4,411 shares ($370K)
06 May 2026	Form 4: Susi Roger E., Director Sold 3,750 shares ($321K) · Sold 3,750 shares ($322K)
01 May 2026	10-Q
01 May 2026	8-K: Results of Operations and Financial Condition

Comments